期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(125)I粒子植入在宫颈癌复发转移治疗中的应用 被引量：3

Application of ^(125)I Radioactive Seeds Implantation for Advanced Uterine Cervical Cancer
在线阅读 下载PDF
导出
摘要 目的探讨125I粒子植入技术治疗宫颈癌综合治疗后盆腔未控或复发患者的可行性。方法回顾性分析2004年4月~10月应用125I粒子植入技术治疗宫颈癌综合治疗后盆腔未控或复发患者9例。结果全部患者术后恢复良好。术后3个月肿块完全缓解(CR)1例,部分缓解(PR)5例,进展(PD)3例。结论125I放射性粒子植入术治疗局部复发转移宫颈癌具有安全有效、创伤小、并发症少、近期疗效显著的优点。 Objective To investigate the feasibility of radioactive seeds implantation for advanced uterine cervical cancer after combined therapy. Methods From April to September of 2004, 9 patients with advanced uterine cervical cancer after combined therapy were enrolled in this study. Results All patients have not serious toxicity among 1 obtained CR, 5 PR, 3 PD. Conclusion Radioactive seeds implantation procedure for advanced uterine cervical cancer after combined therapy has good clinical effects and few complications.
作者 刘孜 王国庆 罗伟 郑伟 张龙 刘隽悦
机构地区 西安交通大学医学院附属第一医院放疗科 陕西省肿瘤医院妇瘤科
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2006年第6期444-446,共3页 Cancer Research on Prevention and Treatment
关键词 放射性粒子 宫颈癌 综合治疗 Radioactive seed Cervical cancer Combined therapy
分类号 R737.33 [医药卫生—肿瘤]
作者简介 刘孜（1960-），女，硕士，主任医师，主要从事妇科肿瘤的基础与临床研究
  • 相关文献

参考文献4

  • 1Nag S, Ellis RJ, Merrick GS, et al. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy[J].Int J Radiat Oncol Biol Phys, 2002,54(2):462-470.
  • 2Chen A, Galloway M, Landreneau R, et al. Intraoperative ^125I brachytherapy for high-risk stage Ⅰ non-small cell lung carcinoma[J].Int J Radiat Oncol Biol Phys, 1999,44(5):1057-1063.
  • 3岳麓.^(125)I籽源组织间照射在肿瘤治疗中的应用[J].国外医学（放射医学核医学分册）,2001,25(1):23-26. 被引量：51
  • 4Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma, Ⅲ: initial mortality finding[J]. Arch Ophthalmol, 2001,119(7) :969-982.

二级参考文献19

  • 1Lazarescu GR, Battista JJ. Analysis of the radiobiolo gy of Ytterbium-169 and Iodine-125 permanent brachytherapy implants[j]. Phys Med Biol, 1997,42:1727-1736.
  • 2Ling CC. Permanent implams using Au-198, Pd-103and I-125: Radiobiological considerations based on the linear quadratic model [J]. Int J Radiat Oncol Biol Phys, 1992,23:81-87.
  • 3Kim JH, Hilaris BS. Iodinc-125 sourcc in interstitial tumor therapy[J]. Radiology, 1975,123:163-169.
  • 4Anderson LL, Kuan HM, Ding IY. Clinical dosimetry with I-125 [A]. In Gorge [ed]. Modern interstitial and intracavitary radation cancer management [C].New York : Masson Publishing, 1981.
  • 5Williamson JF. Physics of brachythcrapy[A]. Perez CA, Brady LW[ed]. Principles and practice of radiation oncology [C]. Third Edition, Philadelphia: Lippincott -Raven, 1997.
  • 6Nath R, Anderson LL, Meli JA, et al. Code of practice for brachytherapy physics: Report of the AAPM radation therpy committee task group NO. 56[J]. Med Phys, 1997,24:1557-1579.
  • 7Wu A, Zwicker D, Sternick ES. Tumor dose specification of I-125 seed implants[J]. Med Phys, 1985,12:27-31.
  • 8Chen Y, Stanton RE, Holst RJ, et al. Treatment planning for prostate implant with loose seeds [J].Med Phys,1997, 24:1141-1145.
  • 9Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachtherapy sources:Recommendations of the AAPM radiation therapy committee task group NO. 43[J]. Med Phys,1995, 22:209-233.
  • 10Williamson JF, Courscy BM, DeWerd LA, et al.Guidence to users of Nycomed Amersham and North American Scientific, Inc, I-125 interstitial sources:Dosimetry and calibration changes: Recommendations of the American Association of physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on low-energy[J]. Med Phys, 1999,26:570-573.

共引文献50

同被引文献31

  • 1杨瑞杰,姜玉良,李金娜,王俊杰.复发性直肠癌CT引导^(125)I粒子植入的剂量学验证[J].中国肿瘤,2009,18(10):848-850. 被引量：17
  • 2柴树德,郑广钧,毛玉权,杨景魁,梁吉祥,闫卫亮.CT引导下经皮穿刺种植放射性^(125)I粒子治疗晚期肺癌[J].中华放射肿瘤学杂志,2004,13(4):291-293. 被引量：92
  • 3李孟达.宫颈复发癌的诊断和治疗[J].实用妇产科杂志,1994,10(5):242-244. 被引量：15
  • 4张福君,吴沛宏,赵明,黄金华,范卫君,顾仰葵,刘健,张亮,卢鸣剑.CT导引下^(125)I粒子植入治疗胰腺癌[J].中华医学杂志,2006,86(4):223-227. 被引量：120
  • 5梁月琴,李永晋.热疗加放疗治疗恶性肿瘤颈部转移30例临床分析[J].肿瘤防治研究,1997,24(1):36-37. 被引量：1
  • 6Hong JH, Tsai CS. Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys, 2004,60:249-257.
  • 7Moore DH, Blessing JA, McQuellon RP, et al. Phase Ⅲ study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncolagy group study. J Clin Oncol,2004,22:3113-3119.
  • 8Tsuda H, Hashiguchi Y, Nishimura S, et al. Phase Ⅰ - Ⅱ study of irinotecan ( CPT-11 ) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer. Br J Cancer, 2004, 91 : 1032-1037.
  • 9Bergk A,Wiener G,Weich V, et al. CT-guided brachytherapy of hepatocellular carcinoma in liver cirrhosis: a novel therapeutic approach. J Hepatol,2005 ,42 :89-89.
  • 10Ebara S, Katayama Y, Tanimoto R, et al. Iodine-125 seed implantation (permanent brachytherapy ) for clinically localized prostate cancer. Acta Med Okayama,2008 ,62 :9-13.

引证文献3

二级引证文献33

肿瘤防治研究
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部